Table 1 Characteristics of cases admitted to hospitals between February 1, 2021 and February 28, 2022, stratified by SARS-CoV-2 vaccination and infection status.

From: Thrombocytopenia and venous thromboembolic events after BNT162b2, CoronaVac, ChAdOx1 vaccines and SARS-CoV-2 infection: a self-controlled case series study

 

Vaccinated

SARS-CoV-2 infection

Thrombocytopenia

 N

3330

1236

 Age in years, mean (SD)

51.5 (19.6)

50.6 (21.6)

 Age in years, n (%)

  

  18–39

891 (26.8)

277 (22.4)

  40–59

958 (28.8)

351 (28.4)

  60+

1359 (40.8)

514 (41.6)

 Male, n (%)

1754 (52.7)

685 (55.4)

 Ethnicity, n (%)

  

  Malay

1901 (57.1)

724 (58.6)

  Chinese

490 (14.7)

155 (12.5)

  Indian

306 (9.2)

105 (8.5)

  Others

541 (16.3)

209 (16.9)

 Non-Malaysian, n (%)

91 (2.7)

40 (3.2)

 Discharged alive, n (%)

3189 (95.0)

1094 (88.5)

 COVID-19 vaccination

  

  BNT162b2

2202 (66.1)

  CoronaVac

992 (29.8)

  ChAdOx1

136 (4.1)

Venous thromboembolism

 N

4124

4193

 Age in years, mean (SD)

52.3 (16.9)

52.6 (15.8)

 Age in years, n (%)

  

  18–39

975 (23.6)

882 (21.0)

  40–59

1520 (36.9)

1694 (40.4)

  60+

1596 (38.7)

1589 (37.9)

 Male, n (%)

1987 (48.2)

2179 (52.0)

 Ethnicity, n (%)

  

  Malay

2461 (59.7)

2656 (63.3)

  Chinese

646 (15.7)

526 (12.5)

  Indian

379 (9.2)

363 (8.7)

  Others

470 (11.4)

415 (9.9)

 Non-Malaysian, n (%)

168 (4.1)

219 (5.2)

 Discharged alive, n (%)

3783 (91.7)

3172 (75.6)

 COVID-19 vaccination, n (%)

  

  BNT162b2

2670 (64.7)

  CoronaVac

1279 (31.0)

  ChAdOx1

175 (4.2)

  1. Vaccinated refers to cases who received at least 1 dose of BNT162b2, CoronaVac, or ChAdOx1 vaccine.
  2. SD standard deviation.